medRxiv
February 15, 2023
Victoria di Virgilio, Amir Minerbi, Jenna Fletcher et al.
1 citation
preprint
Veterans who used psychedelic medicines for non-recreational therapeutic purposes reported improvements in medical and mental health conditions, social interaction, spirituality, and overall function. Analysis of 93 comments from 65 civilian or military veterans identified themes including mysticism and spirituality, functional improvement and self-awareness, social connection and cultural impact, and impact on medical and mental health conditions, as well as neutral impressions and difficult experiences. The findings suggest that psychedelic use is associated with multidimensional wellness improvements beyond the absence of disease, reflecting dynamic interactions with personal, psychophysiological, and socio-environmental factors.
medRxiv
January 21, 2022
Latifah Kamal, Major Pauline Godsell, Bryce P. Mulligan et al.
1 citation
preprint
A dashboard system called SENSOR (Standardized Data Entry and Dashboards for Review of Scientific Studies) was developed to improve how scientific literature reviews communicate data. The system was tested on an existing review about clinical applications of psychedelics for mental health issues. Two team members entered 46 study entries, including 3 articles published after the original review to show ease of updating. The dashboard displayed the data in various visual representations. Using a dynamic, graphical display for review studies proved feasible and offers advantages such as standardizing reporting, centralizing datasets, streamlining submissions, improving collaboration, measuring author contributions, and enhancing patient involvement. Limitations include heterogeneity in study design, dosing, indications, and outcome measures.
medRxiv
May 10, 2023
Victoria di Virgilio, Amir Minerbi, Jagpaul Kaur Deol et al.
preprint
Veterans and civilians who used psychedelic medicines for non-recreational purposes in the previous three years reported improvements across pain, mental health, function, and overall quality of life, with the largest perceived gains in mental health and quality of life and the smallest in pain. Correlations among these domains were highly significant, particularly between function, quality of life, and mental health. No significant differences emerged between specific psychedelic drugs, suggesting the benefits may be class-wide. The study was retrospective, anonymous, and relatively small (65 participants), and lacked a baseline comparison.